Gene · 1022
Papers3,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, Synthesis, and Biological Evaluation of 2,4-Diaminopyrimidine Derivatives as Potent CDK7 Inhibitors. | ACS Med Chem Lett | 2024 | 39140066 | PubTator, text mining | PubMed |
| Understanding the Molecular Landscape of Endometriosis: A Bioinformatics Approach to Uncover Signaling Pathways and Hub Genes. | Iran J Pharm Res | 2024 | 39108650 | PubTator, text mining | PubMed |
| Structural basis of Cdk7 activation by dual T-loop phosphorylation. | Nat Commun | 2024 | 39097586 | PubTator, text mining | PubMed |
| Proteus Syndrome: Case Report and Updated Literature Review. | Arch Plast Surg | 2024 | 39034978 | PubTator, text mining | PubMed |
| Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7. | Antimicrob Agents Chemother | 2024 | 39023263 | PubTator, text mining | PubMed |
| Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer. | Life Sci | 2024 | 39004275 | PubTator, text mining | PubMed |
| Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). | Eur J Med Chem | 2024 | 39004018 | PubTator, text mining | PubMed |
| Recent Advances in the Discovery of Novel Drugs on Natural Molecules. | Biomedicines | 2024 | 38927461 | PubTator, text mining | PubMed |
| Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells. | Mol Cells | 2024 | 38871298 | PubTator, text mining | PubMed |
| Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design. | Structure | 2024 | 38870939 | PubTator, text mining | PubMed |
| CDK7/CDK9 mediates transcriptional activation to prime paraptosis in cancer cells. | Cell Biosci | 2024 | 38858714 | PubTator, text mining | PubMed |
| Exploring isoindolin-1-ones as potential CDK7 inhibitors using cheminformatic tools. | In Silico Pharmacol | 2024 | 38845825 | PubTator, text mining | PubMed |
| CDK7 kinase activity promotes RNA polymerase II promoter escape by facilitating initiation factor release. | Mol Cell | 2024 | 38821049 | PubTator, text mining | PubMed |
| Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. | Oncogene | 2024 | 38811847 | PubTator, text mining | PubMed |
| Impact of CDK Inhibitors on TBXT Expression in Chordoma Cell Lines Including the First Stable Cell Line of a High-Grade Chordoma. | Diagnostics (Basel) | 2024 | 38786326 | PubTator, text mining | PubMed |
| Exploring the conformational landscapes of protein kinases: perspectives from FRET and DEER. | Biochem Soc Trans | 2024 | 38778760 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel potent CDK7 inhibitors. | Bioorg Chem | 2024 | 38761706 | PubTator, text mining | PubMed |
| Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues. | Mol Oncol | 2024 | 38650175 | PubTator, text mining | PubMed |
| A novel and ubiquitous miRNA-involved regulatory module ensures precise phosphorylation of RNA polymerase II and proper transcription. | PLoS Pathog | 2024 | 38640110 | PubTator, text mining | PubMed |
| CDK7 in breast cancer: mechanisms of action and therapeutic potential. | Cell Commun Signal | 2024 | 38605321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1022/papers?page=10